Chapter 0: Introduction to the consensus on primary hyperparathyroidism from the French Society of Endocrinology, French speaking Association of Endocrine Surgery and French Society of Nuclear Medicine - 26/02/25
, Eric Mirallie b, Elif Hindie c, d, Marie-Christine Vantyghem e, Laurent Brunaud fAbstract |
This consensus on primary hyperparathyroidism, drawn up under the aegises of the French Society of Endocrinology (SFE), French speaking Association of Endocrine Surgery (AFCE) and French Society of Nuclear Medicine (SFMN), provides an update on positive, etiological and differential diagnosis and treatment in primary hyperparathyroidism. These recommendations take account of recent increase in the prevalence of primary hyperparathyroidism, due to 1. More systematic routine measurement of blood calcium and improved quality of parathyroid hormone assays, 2. Developments in genetics, 3. The steady increase in life expectancy, affecting the long-term consequences of asymptomatic hyperparathyroidism, 4. Advances in parathyroid imaging, 5. Targeted surgical management, 6. Therapeutic alternatives when surgery is contraindicated, and 7. Better understanding of pathophysiological mechanisms and hence of differential diagnoses, and in particular secondary and tertiary hyperparathyroidism. The consensus is published in French on the Société Française d’Endocrinologie website (www.sfendocrino.org/), and in English in the Annales d’Endocrinologie/Annals of Endocrinology and the Journal of Visceral Surgery. A summary for general practitioners will be made available on the French Health Authority (HAS) website (www.has-sante.fr/).
Le texte complet de cet article est disponible en PDF.Keywords : Primary hyperparathyroidism, Parathyroid adenoma, Hypercalcemia, Hypercalciuria, Osteoporosis, Renal lithiasis, Secondary hyperparathyroidism
Plan
Vol 86 - N° 1
Article 101689- février 2025 Retour au numéro
Article précédent
- Diagnosis and management of children and adult craniopharyngiomas: A French Endocrine Society/French Society for Paediatric Endocrinology & Diabetes Consensus Statement
- Thomas Cuny, Rachel Reynaud, Gérald Raverot, Régis Coutant, Philippe Chanson, Dulanjalee Kariyawasam, Christine Poitou, Cécile Thomas-Teinturier, Bertrand Baussart, Dinane Samara-Boustani, Loïc Feuvret, Carine Villanueva, Chiara Villa, Benjamin Bouillet, Maïthé Tauber, Stéphanie Espiard, Sarah Castets, Albert Beckers, Jessica Amsellem, Marie-Christine Vantyghem, Brigitte Delemer, Nicolas Chevalier, Thierry Brue, Nicolas André, Véronique Kerlan, Thomas Graillon, Isabelle Raingeard, Claire Alapetite, Véronique Raverot, Sylvie Salenave, Anne Boulin, Romain Appay, Florian Dalmas, Sarah Fodil, Lucie Coppin, Camille Buffet, Philippe Thuillier, Frédéric Castinetti, Guillaume Vogin, Laure Cazabat, Emmanuelle Kuhn, Magalie Haissaguerre, Yves Reznik, Bernard Goichot, Anne Bachelot, Peter Kamenicky, Bénédicte Decoudier, Charlotte Planchon, Jean-Arthur Micoulaud-Franchi, Pauline Romanet, David Jacobi, Pauline Faucher, Claire Carette, Hélène Bihan, Delphine Drui, Sylvie Rossignol, Lucile Gonin, Emmanuelle Sokol, Laurent Wiard, Carine Courtillot, Marc Nicolino, Solange Grunenwald, Olivier Chabre, Sophie Christin-Maître, Rachel Desailloud, Dominique Maiter, Laurence Guignat, Aude Brac de la Perrière, Philippe Salva, Didier Scavarda, Fabrice Bonneville, Philippe Caron, Alexandre Vasiljevic, Delphine Leclercq, Christine Cortet, Stephan Gaillard, Frédérique Albarel, Karine Clément, Emmanuel Jouanneau, Henry Dufour, Pascal Barat, Blandine Gatta-Cherifi
- Chapter 1: Epidemiology of primary hyperparathyroidism
- Thomas Cuny, Muriel Mathonnet, Igor Tauveron
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?